Our ChIP data following co-expression of ASXL1 and RUNX1 mutations recognized the deregulation of ID1 in myeloid leukemia cells, suggesting the role of myeloid leukemia transformation by combined mutations were at least partly attributed to the upregulated ID1 expression (Fig. 8). This evidence concerns the gene ID1 and myeloid leukemia.